IMAGINE IF! Accelerator for Life Sciences and Health Tech Ventures – Application Deadline 16th February 2022
Wednesday, 16 February 2022
Apply now to join IMAGINE IF!, an accelerator program for life sciences and health tech ventures providing early-stage science start-ups with extensive opportunities to take your venture to the next level. Benefit from 1:1 mentoring, non-dilutive cash prizes, investors pitching and, a 12-week curriculum.
IMAGINE IF! is an accelerator program for life sciences and health tech ventures. It is one of the most selective programmes in the world with an acceptance rate of < 10% for the global phase. Successful applicants will enjoy a host of benefits for free as well as becoming part of the thriving and exclusive Innovation Forum community of entrepreneurs around the world.
IMAGINE IF! provides early-stage science start-ups with extensive opportunities to take your venture to the next level: tailored mentorship, expert-led sprints and feedback sessions, free advice from leading professional service companies and networking across the Innovation Forum’s platform. At the end of the program, there is a Demo Day when the global finalists will present to a specially selected audience with the chance to pitch in front of top investors and industry leaders to secure non-dilutive capital, free lab space and other benefits.
Click here for more information
Click here to apply
An eligible IMAGINE IF! team is composed of between two and seven members that have together raised less than $300,000 USD (or the equivalent in local currency) in dilutive funding for the project or company that is submitted to the IMAGINE IF! accelerator.
An eligible project or company should also have a strong scientific/technological backbone and should focus on health or healthcare.
We define those as “life sciences and health tech ventures”, which means any business that is based on scientific discoveries, use technology and/or data to create products or services that aim to improve human or animal healthcare and wellbeing.